State Street Corp Arbutus Biopharma Corp Transaction History

State Street Corp

$2.8 Trillion
Q3 2025

A detailed history of State Street Corp transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, State Street Corp holds 4,098,318 shares of ABUS stock, worth $18.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,098,318

Previous 4,459,762 8.1%

Holding current value

$18.5 Million

Previous $13.8 Million 35.02%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$3.08 - $4.9 $1.11 Million - $1.77 Million	-361,444 Reduced 8.1%	4,098,318 $18.6 Million
Q2 2025 Aug 14, 2025	BUY	$2.88 - $3.61 $277,214 - $347,480	96,255 Added 2.21%	4,459,762 $13.8 Million
Q1 2025 May 15, 2025	SELL	$3.06 - $3.59 $2.03 Million - $2.38 Million	-663,122 Reduced 13.19%	4,363,507 $15.2 Million
Q4 2024 Feb 14, 2025	BUY	$3.18 - $4.2 $1.97 Million - $2.6 Million	619,496 Added 14.06%	5,026,629 $16.4 Million
Q3 2024 Nov 14, 2024	BUY	$3.12 - $4.56 $4.59 Million - $6.72 Million	1,472,652 Added 50.18%	4,407,133 $17 Million

Q2 2024 Aug 14, 2024	BUY	$2.52 - $3.63 $812,929 - $1.17 Million	322,591 Added 12.35%	2,934,481 $9.07 Million
Q1 2024 May 15, 2024	BUY	$2.26 - $2.92 $486,193 - $628,179	215,130 Added 8.98%	2,611,890 $6.74 Million
Q4 2023 Feb 14, 2024	BUY	$1.69 - $2.54 $397,756 - $597,811	235,359 Added 10.89%	2,396,760 $5.99 Million
Q3 2023 Nov 14, 2023	SELL	$1.9 - $2.27 $91,006 - $108,728	-47,898 Reduced 2.17%	2,161,401 $4.39 Million
Q2 2023 Aug 14, 2023	BUY	$2.24 - $3.06 $316,393 - $432,215	141,247 Added 6.83%	2,209,299 $5.08 Million
Q1 2023 May 15, 2023	BUY	$2.23 - $3.1 $95,858 - $133,256	42,986 Added 2.12%	2,068,052 $6.27 Million
Q4 2022 Feb 14, 2023	BUY	$1.91 - $2.85 $26,147 - $39,016	13,690 Added 0.68%	2,025,066 $4.72 Million
Q3 2022 Nov 15, 2022	BUY	$1.88 - $2.88 $98,617 - $151,073	52,456 Added 2.68%	2,011,376 $3.84 Million
Q2 2022 Aug 15, 2022	BUY	$1.98 - $3.17 $364,288 - $583,229	183,984 Added 10.37%	1,958,920 $5.31 Million
Q1 2022 May 16, 2022	BUY	$2.42 - $3.98 $220,478 - $362,605	91,107 Added 5.41%	1,774,936 $5.29 Million
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $85,357 - $126,526	27,446 Added 1.66%	1,683,829 $6.55 Million
Q3 2021 Nov 15, 2021	BUY	$2.65 - $4.62 $1.33 Million - $2.31 Million	500,289 Added 43.27%	1,656,383 $7.11 Million
Q2 2021 Aug 16, 2021	BUY	$2.5 - $3.51 $2.75 Million - $3.86 Million	1,099,484 Added 1942.21%	1,156,094 $3.5 Million
Q4 2020 Feb 16, 2021	BUY	$2.76 - $4.97 $12,971 - $23,359	4,700 Added 9.05%	56,610 $201,000
Q3 2020 Nov 10, 2020	BUY	$1.75 - $6.2 $90,842 - $321,842	51,910 New	51,910 $162,000
Q2 2020 Aug 14, 2020	SELL	$0.91 - $2.36 $10,634 - $27,578	-11,686 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$1.01 - $3.42 $11,802 - $39,966	11,686 New	11,686 $12,000

Others Institutions Holding ABUS

# of Institutions

194

Shares Held

118M

Call Options Held

2.67M

Put Options Held

693K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $678M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Arbutus Biopharma Corp Transaction History